Naveed Sattar

69PUBLICATIONS
227CO-AUTHORS
PharmacogenomicsMedical parasitologyCardiology (incl. cardiovascular diseases)NanomedicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (69)

|Sep 03, 2026
SGLT Inhibitors for Heart and Kidney Disease in Type 1 Diabetes.

|Apr 06, 2026
Estimating the True MACE Benefits From Tirzepatide in SURPASS-CVOT Using an Imputed Placebo Analysis of REWIND.

Naveed Sattar, Hertzel C Gerstein, David D'Alessio

|Jan 22, 2026
Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial.

Ayodele Odutayo, Deepak L Bhatt, Vikas S Sridhar

|Jul 29, 2025
Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA-MI Trial.

Robert F Storey, John Deanfield, Stefan James

|Mar 29, 2025
Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials.

Matthew M Y Lee, Naveed Sattar, Rodica Pop-Busui

|Mar 29, 2025
Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial.

Nikolaus Marx, John E Deanfield, Johannes F E Mann

Pageof 12

Frequent Collaborators

14 joint publications

Naveed Sattar

8 joint publications

Deepak L Bhatt

8 joint publications

Ambarish Pandey

7 joint publications

David Z I Cherney